Using BTK Inhibitors for Chronic Lymphocytic Leukemia: Online Education Significantly Improved the Knowledge and Competence of Hematologists/Oncologists

Hematological Oncology - United Kingdom
doi 10.1002/hon.54_2631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Online Education Significantly Improved the Competence of Hematologists/Oncologists and Nurses Regarding the Use of BTK Inhibitors for Mantle Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Common Genetic Variation Contributes Significantly to the Risk of Developing Chronic Lymphocytic Leukemia

Haematologica
Hematology
2012English

Chronic Lymphocytic Leukemia

Current Opinion in Hematology
Hematology
1998English

Chronic Lymphocytic Leukemia

Orvosi Hetilap
Medicine
2008English

The Development and Current Use of BCL-2 Inhibitors for the Treatment of Chronic Lymphocytic Leukemia

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2017English

Chronic Lymphocytic Leukemia

ASH Image Bank
2003English

Chronic Lymphocytic Leukemia

Molecular and Translational Medicine
2018English

Chronic Lymphocytic Leukemia

Hematology/Oncology Clinics of North America
OncologyHematology
2004English

Preparing for a Paradigm Shift in the Treatment of Ovarian Cancer: Effect of Online CME on Oncologists' Knowledge and Competence

Gynecologic Oncology
GynecologyOncologyObstetrics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy